Related Experiment Videos
Pulmonary alveolar proteinosis complicating chronic myelogenous leukemia
Abstract:
Pulmonary alveolar proteinosis (PAP) has been reported in 5 patients with chronic myelogenous leukemia and approximately 20 patients with other hematologic malignancies. These patients have had recurrent infections, frequently by opportunistic organisms. This susceptibility suggests that they have impaired cell-mediated immunity. In the case reported, splenectomy early in the course of illness may have contributed to the susceptibility to infection and PAP. Awareness of the possibility of pulmonary alveolar proteinosis in a patient with progressive dyspnea and unexplained pulmonary infiltrates should prompt early open lung biopsy to establish the diagnosis. Therapeutic pulmonary lavage is currently the treatment of choice.
Insights
Pulmonary alveolar proteinosis (PAP) is a rare lung disease that can affect patients with hematologic malignancies, increasing infection risk. Early diagnosis via lung biopsy and treatment with therapeutic lavage are crucial for managing this condition.
Area of Science:
- Pulmonology
- Hematology
- Immunology
Background:
- Pulmonary alveolar proteinosis (PAP) is a rare lung disease.
- It has been reported in patients with hematologic malignancies, including chronic myelogenous leukemia.
- These patients often experience recurrent infections, suggesting compromised immunity.
Observation:
- A case study highlights PAP in a patient with hematologic malignancy.
- The patient experienced recurrent infections, potentially linked to impaired cell-mediated immunity.
- Early splenectomy in this case may have increased susceptibility to infection and PAP.
Findings:
- Patients with hematologic malignancies are at risk for PAP.
- Impaired cell-mediated immunity is a likely factor in PAP development in these patients.
- Pulmonary infiltrates and dyspnea warrant investigation for PAP.
Implications:
- Increased awareness of PAP in hematologic malignancy patients is needed.
- Early open lung biopsy is recommended for diagnosis.
- Therapeutic pulmonary lavage is the primary treatment for PAP.